Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2014 Dec 12;8:1713–1720. doi: 10.2147/PPA.S64709

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2014 Cimino et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License

The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.

PMC Copyright notice

The five treatment scenarios with different methods of preparation and injection delivery systems.

Notes: Scenario 1 represents: Advate^® (Baxter AG, Vienna, Austria); scenario 2 represents: Fahndi^® (Instituto Grifols, Barcelona, Spain), Kogenate^® (Bayer Pharma AG, Berlin, Germany), ReFacto AF^® (R2-kit; Pfizer Limited, Sandwich, United Kingdom); scenario 3 represents: Haemoctin^® (Biotest Pharma GmbH, Dreieich, Germany), Helixate^® (Bayer Pharma AG); scenario 4 represents: Aafact^® (Sanquin, Amsterdam, the Netherlands), Octanate^® (Octapharma Ltd, Manchester, United Kingdom); scenario 5 represents: ReFacto AF^® FuseNGo^® (Pfizer Ltd.).